This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis

Sponsored by Hepatopancreatobiliary Surgery Institute of Gansu Province

About this trial

Last updated 6 years ago

Study ID

ENGBD in acute cholecystitis

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18 to 90 Years
All Sexes

Trial Timing

Ended 6 years ago

What is this trial about?

Comparison of ENGBD and PTGBD methods on clinical outcomes and the difficulty of cholecystectomy in later stage in patients with acute suppurative cholecystitis.

What are the participation requirements?

Inclusion Criteria

* Acute suppurative cholecystitis

* Who can not tolerate or unsuitable for cholecystectomy

Exclusion Criteria

* Unwillingness or inability to consent for the study

* Coagulation dysfunction (INR> 1.5) and low peripheral blood platelet count (<50×10^9 / L) or using anti-coagulation drugs

* Bile duct stones

* Prior surgery of Bismuth Ⅱ, Roux-en-Y and Cholangiojejunostomy

* Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage or perforation, severe liver disease(such as decompensated liver cirrhosis, liver failure and so on), septic shock

* Any malignant

* Pregnant women or breastfeeding